A new study aims to reduce hepatitis C (HCV) transmission among young adults who inject drugs. The study will equip participants with strategies to avoid situations and practices that put them at risk of contracting HCV.
Hospitals are struggling to deal with an overwhelming number of patients with diseases that result from intravenous opioid use, including hepatitis C, endocarditis and the antibiotic-resistant infection MRSA.
Seattle has approved the nation’s first two safe-injection sites for people using heroin and other illegal drugs, The Washington Post reports. City officials said the sites are a drastic but necessary response to the opioid epidemic.